Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Metabolic Syndrome 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Disease 1Diabetes Mellitus 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 26Blood Specimen Collection 19Radiotherapy 17Gene Expression Profiling 11Immunohistochemistry 9Cetuximab 6Polymerase Chain Reaction 5Nivolumab 5Immunotherapy 5Cisplatin 5Microarray Analysis 4Drug Therapy 4Biopsy 4pembrolizumab 3Tissue Banks 3Therapeutics 3Reverse Transcriptase Polymerase Chain Reaction 3Restraint, Physical 3Radiotherapy, Intensity-Modulated 3Radiation 3Observation 3Interviews as Topic 3Immunologic Techniques 3Immunoenzyme Techniques 3Flow Cytometry 3Chemotherapy, Adjuvant 3Surgical Procedures, Operative 2Quality of Life 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Head and Neck Neoplasms × DNA × Clear all
NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡